Craft
Bristol-Myers Squibb

Bristol-Myers Squibb

Stock Price

$69.2

2023-03-02

Market Capitalization

$145.2 B

2023-03-02

Revenue

$46.2 B

FY, 2022

Bristol-Myers Squibb Summary

Company summary

Overview
Bristol-Myers Squibb is a company that provides biopharmaceutical products. It focuses on discovering, developing, and delivering medicines for patients facing diseases such as oncology (both solid tumors and hematology), immunology, cardiovascular, and fibrosis. The company markets medicines, including ABECMA, BREYANZI, EVOTAZ, REBLOZYL, THALOMID, NULOJIX, etc.
Type
Public
Status
Active
Founded
1887
HQ
New York, NY, US | view all locations
Website
https://www.bms.com/
Cybersecurity rating
ESG rating
60-79 out of 100|View all ESG data
Sectors

Key people

  • Giovanni Caforio

    Giovanni Caforio, Chairman of the Board and Chief Executive Officer

  • Neil Bence

    Neil Bence, Vice President, Head of Oncology Discovery, San Diego Site Head

  • Nisha Zaidi

    Nisha Zaidi, Vice President, Global Alliances

  • Sunil Patel

    Sunil Patel, Executive Director - BD Transactions - Cardiovascular, Fibrosis, Immunology, Neuroscience

Operating MetricsView all

Research and Development Centers

11
8.3%

FY, 2021

Phase II Trials Products (Oncology)

15
15.4%

FY, 2021

Phase III Trials Products (Oncology)

7
16.7%

FY, 2021

LocationsView all

85 locations detected

  • New York, NY HQ

    United States

    430 E 29th St 14th Floor

  • Atlanta, GA

    United States

    950 East Paces Ferry Rd NE

  • Cambridge, MA

    United States

    100 Binney St

  • Columbus, OH

    United States

    999 Polaris Pkwy #100

  • Devens, MA

    United States

    38 Jackson Rd

  • Irvine, CA

    United States

    7700 Irvine Center Dr

and 79 others

Bristol-Myers Squibb Financials

Summary financials

Revenue (FY, 2022)
$46.2B
Gross profit (FY, 2022)
$36.0B
Net income (FY, 2022)
$6.3B
Cash (FY, 2022)
$9.1B
Enterprise value
$175.4B

Footer menu